T1	intervention 49 87	silver carboxymethylcellulose dressing
T2	condition 91 115	surgical site infections
T3	average-age 576 585	â‰¥18 years
T4	eligibility 587 665	diagnosed with breast cancer, undergoing breast conserving or ablative surgery
T5	outcome-Measure 830 856	SSI following CDC criteria
T6	No-of-participants 869 872	230
T7	intervention-participants 897 900	106
T8	control-participants 926 929	124
T9	control 930 938	controls
T10	intervention-value 940 945	Seven
T11	intervention-value 956 960	6.6%
T12	outcome 962 975	developed SSI
T13	control-value 1001 1003	16
T14	control-value 1014 1019	12.9%
T15	outcome 1237 1245	SSI rate
T16	intervention-value 1250 1251	1
T17	intervention-participants 1252 1254	56
T18	intervention-value 1256 1260	1.8%
T19	control-value 1287 1288	7
T20	control-participants 1289 1291	65
T21	control-value 1293 1298	10.8%
T22	outcome 1385 1405	patient satisfaction
T23	outcome 1469 1501	dressing changes within 48 hours
T24	outcome 1547 1560	re-operations
T25	intervention-value 1562 1564	0%
T26	control-value 1569 1573	3.2%
T27	outcome 1602 1631	wound-related treatment costs
T28	outcome 1763 1794	attributable costs of SSI model
